Global Anticoccidial Drugs Market Size, Share & Trends Analysis Report, By Drug Type (Antibiotic, Ionophore, Chemical Derivative), By Animal Type (Poultry, Swine, Cattle, and Companion Animal) and Forecast, 2020-2026.
The anticoccidial drugs market is projected to grow at a modest growth rate at a CAGR of around 4% during the forecast period 2020-2026. Coccidiosis is a treatable disease that is found in animals especially chickens. Increasing meat consumption, growing awareness related to healthy food, increasing disposable income, rise in the possibility of zoonotic diseases are some of the key factors for the growth of the anticoccidial drugs industry across the globe.
Besides, government support to poultry and dairy farming to increase the disposable income of the rural population is also one of the major factors for market growth. In addition, in recent years, the veterinary drug supply chain has also developed significantly in emerging economies. However, a vaccine against coccidiosis is also available in the European market which reduces the need for anticoccidial drugs. Besides, in some regions, herbal medicines are also widely used for the treatment of coccidiosis which is acting as a restraining factor for the market growth.
The global anticoccidial drugs market is divided on the basis of drug type and dosage type. By drug type, the market is divided into antibiotics, ionophore, and chemical derivative. Ionophores will hold the major market share during the forecast period. By animal type, the market is divided into poultry, swine, cattle, companion animal, and others. Poultry will hold the largest market share during the forecast period.
By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to hold the major market share. Strict government regulation, well-developed healthcare facilities for animals, high per capita meat consumption are the major factor for the considerable market share of the region. Moreover, Asia-Pacific is expected to have lucrative market growth during the forecast period. Government support for livestock agriculture, increasing meat consumption, and rising awareness toward healthy food are some of the key factors for the growth of the market in the region.
The anticoccidial market is a fragmented market and some of the key players operating in the market include Zoetis, Inc., Bayer AG, BOEHRINGER Ingelheim International GmbH, Ceva Santé Animale, Huvepharma EOOD, Merck & Co., Inc., Venkateshwara Hatcheries Pvt. Ltd., Vetoquinol S.A. and Virbac S.A. The companies are adopting growth strategies including mergers & acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.
Research Methodology
The market study of the global anticoccidial drugs market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to breakdown the market in the various segment, derive total market size, market forecast, and growth rates. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of the reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
The anticoccidial drugs market is projected to grow at a modest growth rate at a CAGR of around 4% during the forecast period 2020-2026. Coccidiosis is a treatable disease that is found in animals especially chickens. Increasing meat consumption, growing awareness related to healthy food, increasing disposable income, rise in the possibility of zoonotic diseases are some of the key factors for the growth of the anticoccidial drugs industry across the globe.
Besides, government support to poultry and dairy farming to increase the disposable income of the rural population is also one of the major factors for market growth. In addition, in recent years, the veterinary drug supply chain has also developed significantly in emerging economies. However, a vaccine against coccidiosis is also available in the European market which reduces the need for anticoccidial drugs. Besides, in some regions, herbal medicines are also widely used for the treatment of coccidiosis which is acting as a restraining factor for the market growth.
The global anticoccidial drugs market is divided on the basis of drug type and dosage type. By drug type, the market is divided into antibiotics, ionophore, and chemical derivative. Ionophores will hold the major market share during the forecast period. By animal type, the market is divided into poultry, swine, cattle, companion animal, and others. Poultry will hold the largest market share during the forecast period.
By geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to hold the major market share. Strict government regulation, well-developed healthcare facilities for animals, high per capita meat consumption are the major factor for the considerable market share of the region. Moreover, Asia-Pacific is expected to have lucrative market growth during the forecast period. Government support for livestock agriculture, increasing meat consumption, and rising awareness toward healthy food are some of the key factors for the growth of the market in the region.
The anticoccidial market is a fragmented market and some of the key players operating in the market include Zoetis, Inc., Bayer AG, BOEHRINGER Ingelheim International GmbH, Ceva Santé Animale, Huvepharma EOOD, Merck & Co., Inc., Venkateshwara Hatcheries Pvt. Ltd., Vetoquinol S.A. and Virbac S.A. The companies are adopting growth strategies including mergers & acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.
Research Methodology
The market study of the global anticoccidial drugs market is incorporated by extensive primary and secondary research conducted. Secondary research has been conducted to breakdown the market in the various segment, derive total market size, market forecast, and growth rates. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of the reports.
Secondary Sources Include
- Financial reports of companies involved in the market
- Authentic public databases
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
- Global Anticoccidial Drugs Market Research and Analysis, By Drug Type
- Global Anticoccidial Drugs Market Research and Analysis, By Animal Type
The Report Covers
- Comprehensive research methodology of the Global Anticoccidial Drugs Market.
- A detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the Global Anticoccidial Drugs Market.
- Insights about market determinants which are stimulating the Global Anticoccidial Drugs Market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
A selection of companies mentioned in this report includes:
- Bayer AG
- Bioproperties Pty. Ltd.
- BOEHRINGER Ingelheim International GmbH
- Ceva Santé Animale
- Elanco Animal Health Inc.
- Huvepharma EOOD
- Impextraco N.V.
- Kemin Industries, Inc.
- Merck & Co., Inc.
- Phibro Animal Health Corp.
- Qilu Animal Health Products Co., Ltd.
- Schering-Plough Corp.
- Venkateshwara Hatcheries Pvt. Ltd.
- Vetoquinol S.A.
- Virbac S.A.
- Zoetis, Inc.
